학술논문

ASSESSING THE CLINICAL UTILITY OF A PROTEOMICS-BASED CARDIOVASCULAR RISK TEST TO GUIDE RISK-CONCORDANT TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Document Type
Article
Source
Journal of the American College of Cardiology (JACC). 2024 Supplement, Vol. 83 Issue 13, p1891-1891. 1p.
Subject
*TYPE 2 diabetes
*CARDIOVASCULAR diseases risk factors
Language
ISSN
0735-1097